453 related articles for article (PubMed ID: 27596150)
1. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
[TBL] [Abstract][Full Text] [Related]
2. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
[TBL] [Abstract][Full Text] [Related]
3. Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study.
Pearce ME; Bartlett SR; Yu A; Lamb J; Reitz C; Wong S; Alvarez M; Binka M; Velásquez Garcia H; Jeong D; Clementi E; Adu P; Samji H; Wong J; Buxton J; Yoshida E; Elwood C; Sauve L; Pick N; Krajden M; Janjua NZ
BMC Womens Health; 2021 Sep; 21(1):330. PubMed ID: 34511082
[TBL] [Abstract][Full Text] [Related]
4. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
Janjua NZ; Kuo M; Chong M; Yu A; Alvarez M; Cook D; Armour R; Aiken C; Li K; Mussavi Rizi SA; Woods R; Godfrey D; Wong J; Gilbert M; Tyndall MW; Krajden M
PLoS One; 2016; 11(3):e0150176. PubMed ID: 26954020
[TBL] [Abstract][Full Text] [Related]
5. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.
Janjua NZ; Yu A; Kuo M; Alvarez M; Cook D; Wong J; Tyndall MW; Krajden M
BMC Infect Dis; 2016 Jul; 16():334. PubMed ID: 27436414
[TBL] [Abstract][Full Text] [Related]
6. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
[TBL] [Abstract][Full Text] [Related]
7. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
8. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
9. Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort.
Islam N; Krajden M; Gilbert M; Gustafson P; Yu A; Kuo M; Chong M; Alvarez M; Wong J; Tyndall MW; Janjua NZ
J Viral Hepat; 2017 May; 24(5):421-429. PubMed ID: 27885757
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
[TBL] [Abstract][Full Text] [Related]
11. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
[TBL] [Abstract][Full Text] [Related]
12. Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study.
Makuza JD; Jeong D; Binka M; Adu PA; Cua G; Yu A; Velásquez García HA; Alvarez M; Wong S; Bartlett S; Karim ME; Yoshida EM; Ramji A; Krajden M; Janjua NZ
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423186
[TBL] [Abstract][Full Text] [Related]
13. Shift in disparities in hepatitis C treatment from interferon to DAA era: A population-based cohort study.
Janjua NZ; Islam N; Wong J; Yoshida EM; Ramji A; Samji H; Butt ZA; Chong M; Cook D; Alvarez M; Darvishian M; Tyndall M; Krajden M
J Viral Hepat; 2017 Aug; 24(8):624-630. PubMed ID: 28130810
[TBL] [Abstract][Full Text] [Related]
14. Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.
Butt ZA; Mak S; Gesink D; Gilbert M; Wong J; Yu A; Wong S; Alvarez M; Chong M; Buxton J; Tyndall M; Krajden M; Janjua NZ
J Viral Hepat; 2019 Mar; 26(3):373-383. PubMed ID: 30447122
[TBL] [Abstract][Full Text] [Related]
15. What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.
Krajden M; Cook DA; Wong S; Yu A; Butt ZA; Rossi C; Darvishian M; Alvarez M; Buxton JA; Tyndall M; Janjua NZ
Int J Drug Policy; 2019 Oct; 72():114-122. PubMed ID: 31229445
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
17. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada.
Binka M; Butt ZA; McKee G; Darvishian M; Cook D; Wong S; Yu A; Alvarez M; Samji H; Wong J; Krajden M; Janjua NZ
Int J Infect Dis; 2021 May; 106():246-253. PubMed ID: 33771673
[TBL] [Abstract][Full Text] [Related]
18. Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.
Miller LS; Millman AJ; Lom J; Osinubi A; Ahmed F; Dupont S; Rein D; Vellozzi C; Harris AM
J Viral Hepat; 2020 Jan; 27(1):13-19. PubMed ID: 31505088
[TBL] [Abstract][Full Text] [Related]
19. Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
Ross J; Rupasinghe D; Avihingsanon A; Lee MP; Pujari S; Sharp G; Kumarasamy N; Khusuwan S; Khol V; Agus Somia IK; Pham TN; Kiertiburanakul S; Choi JY; Duy Do C; Sohn AH; Jiamsakul A;
PLoS One; 2023; 18(6):e0287909. PubMed ID: 37379314
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ
CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
